Population characteristics and outcomes were retrospectively compared for critically ill patients with nosocomial bacteremia caused by antibiotic-susceptible (AB-S; ) or antibiotic-resistant (AB-R; ) n p 208 n p 120 gram-negative bacteria. No significant differences in severity of illness and comorbidity factors were seen between groups. Patients with bacteremia caused by AB-R strains had a longer hospitalization before the onset of the bacteremia. The in-hospital mortality for patients with bacteremia caused by AB-S strains was 41.8%; for patients infected with AB-R strains, it was 45.0% ( ). A multivariate survival analysis demonstrated P p .576 that older age ( ), a high-risk source of bacteremia (abdominal and lower respiratory tract; P p .009 P p ), and a high acute physiology and chronic health evaluation II-related expected mortality ( ) were .031 P p .032 independently associated with in-hospital mortality ( ). Antibiotic resistance in nosocomial bacteremia P ! .05 caused by gram-negative bacteria does not adversely affect the outcome for critically ill patients.
considerable percentage of all bloodstream infections [2] . In ICUs in the United States and Europe, patterns of reduced susceptibility to antibiotics were found among gram-negative bacteria [3, 4] . Despite the high prevalence of antibiotic resistance among gram-negative bacteria causing bacteremia, the clinical consequences of resistance remain unclear. The main objective of our study was to evaluate the relationship between antibiotic resistance in gram-negative bacteria causing bacteremia and the clinical outcomes for critically ill patients. Secondary objectives were to compare the length of the ICU stay and hospitalization for patients with bacteremia caused by antibiotic-susceptible (AB-S) or antibioticresistant (AB-R) gram-negative strains.
METHODS

Setting.
This study was performed in the ICU of the 1060-bed Ghent University Hospital in Ghent, Belgium. The ICU has 54 beds and includes a medical and surgical ICU, an ICU for cardiac surgery, and an ICU for severely burned patients. No significant changes in mean age of patients, length of the ICU stay, or acute physiology and chronic health evaluation (APACHE) II score [5] were observed during the study period.
Study design and data collection. We conducted a retrospective, observational cohort study that included ICU patients with nosocomial, microbiologically documented bacteremia caused by gram-negative bacteria. We compared data from patients with bacteremia caused by AB-S gram-negative bacteria with data from patients with bacteremia caused by AB-R gramnegative bacteria. In-hospital mortality (mortality rate for 3 evaluation points) was the principal outcome variable evaluated. We also assessed secondary outcomes, including length of stay in the ICU and in the hospital and prevalence of acute organ failure.
The study included critically ill adult patients who were admitted to the ICU during a 9-year period (January 1992-December 2000). All microbiologically documented nosocomial bloodstream infections are prospectively screened by the center for infection control. This hospital-wide case-based surveillance program was used to perform a retrospective search for ICU patients with bacteremia caused by gram-negative bacteria. Every patient whose ICU stay was complicated by this bloodstream infection was assessed in our analysis. For ICU patients who developed 11 case of bacteremia caused by gramnegative bacteria, only the first episode was considered. Patients with hemocultures that yielded 11 type of gram-negative bacteria of which at least 1 strain was AB-R were included in the AB-R group.
Definitions. Bacteremia was considered to be nosocomial when it was diagnosed at least 48 h after hospital admission. "Gram-negative bacteremia" was defined as the presence of gram-negative bacteria in the blood, documented by at least 1 positive hemoculture. Hemocultures were routinely performed when the patient's temperature was 138.4ЊC or when infection was suspected on clinical grounds; blood samples were processed following the BacT/Alert (Organon Teknika) procedure. A 10-mL blood culture inoculum was standard. "Antibiotic resistance" was defined as in vitro resistance to ceftazidime. In our hospital, ceftazidime resistance is considered to be an indicator of epidemic extended-spectrum b-lactamase-producing strains or hyperproducers of b-lactamases, and, therefore, it is a sign of infection with organisms that are resistant to multiple drugs [6, 7] . Because susceptibility patterns for Pseudomonas aeruginosa vary, such isolates were considered to be AB-R when resistance to one of the following antipseudomonal antibiotics was seen: piperacillin, ciprofloxacin, ceftazidime, and imipenem [8] .
Antibiotic resistance was determined according to methods for disk-diffusion testing recommended by the National Committee for Clinical Laboratory Standards [9] . For the sake of convenience, cases of bacteremia were designated "AB-S bacteremia" or "AB-R bacteremia," depending on the antibioticresistance status of the isolated organisms. During the study period, no changes in microbiologic laboratory techniques were seen. The source of the bacteremia was determined by intensive care physicians and microbiologists, on the basis of the isolation of gram-negative bacteria from the presumed portal of entry and clinical evaluation. For the purpose of analysis, sources of bacteremia were divided into 3 categories: low risk (associated mortality, р30%), which were sinus, urinary tract, intravenous catheter, and soft-tissue sources; intermediate risk (associated mortality, 31%-50%), which were primary sources of bacteremia; and high risk (associated mortality, 150%), which were lower respiratory tract and abdominal sources. Patients with 11 possible source of bacteremia (e.g., 1 low-risk and 1 highrisk source) were considered to have a high-risk source.
Antibiotic therapy was considered to be "appropriate" if the drugs used had in vitro activity against the isolated strain. We considered antibiotic therapy to be "inadequate" if the drugs used did not have in vitro activity against the isolated strain or if the patient did not receive antibiotic treatment. The delay in the initiation of appropriate antibiotic treatment was calculated from the day of onset of bacteremia. "Acute respiratory failure" was defined as ventilator dependence; "acute renal failure," as the need for renal replacement therapy; and "hemodynamic instability," as the need for vasopressive or inotropic support during the ICU stay. For the comparison of outcomes, survival status was evaluated at 14 and 28 days after the onset of bacteremia and at the end of the hospital stay (all 3 evaluation points are included in in-hospital mortality).
Statistical analysis.
Continuous variables are given as or as median (lower-upper quartile), depending mean ‫ע‬ SD on the distribution. Comparative analyses were done with the Mann-Whitney U test or the x 2 test, as appropriate. Survival curves were prepared by means of the Kaplan-Meier method, and univariate survival distributions were compared by the logrank test. To assess the relationship between in-hospital mortality and a set of independent variables, a multivariate survival analysis was used (Cox proportional hazard model); hazard ratios and 95% CIs are reported. In this multivariate analysis, continuous variables were handled continuously. Variables entered in the Cox regression model were required to have a plausible relationship with mortality, to avoid spurious associations. Statistical analyses were performed using Statistica, version 4.5 (StatSoft), and SPSS, version 9.0. All tests were 2 tailed; was considered to be statistically significant. P ! .05
RESULTS
During the study period, 29,727 patients were admitted to the ICU. Among these, 328 patients were identified as having gram- negative bacteremia and were included in the study cohort (a prevalence of 11.0 cases of gram-negative bacteremia per 1000 ICU admissions). The mean age of the patients was 54 ‫ע‬ years. The mean APACHE II score was , and the 17.2 23 ‫ע‬ 8.9 mean APACHE II-related expected mortality was 42% ‫ע‬ . Fifty-four percent of the patients were admitted to the 27.8% ICU after a surgical procedure; 75% of these patients had nonelective surgery. Twenty percent of the patients were admitted after experiencing trauma.
Among the 328 cases of bacteremia included in the analysis, 369 gram-negative isolates were identified. The most frequently detected gram-negative microorganisms were Escherichia coli
n p 52 n p 51 and Serratia species ( ). In 36.6% (120 of 328) of the n p 27 cases of bacteremia, the strain involved was AB-R. During the study period, the yearly rate of AB-R bacteremia remained stable ( ) (data not shown). P p .495 Outcome of hospital stay. Mortality rates at 14 days, at 28 days, and at the end of the hospital stay were, respectively, 26%, 35%, and 43%. The characteristics of the patients who died in the hospital and the characteristics of those who survived are compared in table 1. Patients who died in the hospital generally were older and had higher APACHE II scores and APACHE II-related expected mortality, and the prevalence of organ failure was also higher in this group. These patients had a shorter ICU stay and a shorter hospitalization. Of all bacteremia-associated factors, only infection with P. aeruginosa and high-risk sources of bacteremia were more prevalent among nonsurvivors (table 2) .
Patients with AB-S bacteremia versus those with AB-R bacteremia. The population characteristics of patients with AB-S gram-negative bacteremia and those with AB-R gram-negative bacteremia are listed in tables 1 and 2. Polymicrobial bloodstream infections were more likely to occur in the AB-R group. Furthermore, no important differences in severity of illness were found, but patients with AB-R bacteremia had a longer stay in the ICU, as well as in the hospital. This seems to be the consequence of a longer hospitalization before the onset of the bacteremia; length of stay (both in ICU and hospital) after the onset of the bacteremia was not different.
Antibiotic resistance was not associated with higher mortality rates (table 1). Figure 1 shows the survival curves for both groups from the onset of bacteremia to the end of hos- pitalization. The mortality rates for the 2 groups were very similar ( ). At the end of the hospitalization period, P p .319 mortality rates for patients with AB-S bacteremia and those with AB-R bacteremia were, respectively, 41.8% and 45.0% ( ). To adjust for differences in clinical virulence, out-P p .576 come comparisons for the 2 groups of patients were performed, according to the different types of gram-negative microorganisms involved. When patients were stratified by most-prevalent bacteria, no statistically significant difference in mortality was seen between the 2 groups ( ; NOTE. Associations were assessed using multivariate survival analysis (Cox proportional-hazard model). APACHE, acute physiology and chronic health evaluation. ble 4). Acute renal failure and bacteremia caused by P. aeruginosa had an association with in-hospital mortality that was of borderline significance ( ). P ! .1
DISCUSSION
It is presumed that infections caused by AB-R bacteria result in higher mortality, longer hospitalizations, and greater costs than do infections caused by AB-S bacteria, although few data support this intuitive concept [10] . The assumption that infections caused by AB-R bacteria are associated with a higher mortality rate may be based on the possibility that appropriate antibiotic therapy will be initiated later for such infections than for infections caused by AB-S bacteria. Although some studies have described very high mortality rates in association with infections caused by AB-R P. aeruginosa and Acinetobacter baumannii [8, 11] , the causal link between antibiotic resistance and fatal bacteremia remains unclear.
Comparisons of the outcomes for patients with AB-R bacteremia and for patients with AB-S bacteremia can be difficult to perform: important differences in demographic characteristics between the populations are repeatedly observed in studies of bacteremia caused by AB-R gram-positive bacteria [12] [13] [14] . In the present study, no important differences in severity of illness (as measured by the APACHE II score) or prevalence of acute organ failure hampered the outcome comparison. Polymicrobial bloodstream infections were seen more frequently among patients with AB-R bacteremia. Although this is considered to be an ominous sign [15, 16] , it has been demonstrated elsewhere that the mortality associated with polymicrobial bacteremia in ICU patients is not necessarily higher than that associated with monomicrobial bacteremia [17] . In our study, polymicrobial bacteremia was not associated with higher in-hospital mortality on either univariate or multivariate analysis.
Our data revealed that the mortality associated with AB-R gram-negative bacteremia is not higher than that associated with AB-S bacteremia. Although mortality is high in both groups of patients, the observed mortality rates are in line with the APACHE II-related expected mortality. In a retrospective study, Menashe et al. [18] also found no significant increase in mortality among patients with bacteremia caused by extendedspectrum b-lactamase-producing Enterobacteriaceae (50%, vs. 38% among patients with bacteremia caused by non-extendedspectrum b-lactamase-producing isolates;
), but their P p .367 study cohort was small ( ). Harbarth et al. [16] , in a n p 55 large retrospective study, also failed to demonstrate that antibiotic resistance had a major clinical effect on outcome for patients with gram-negative bacteremia. However, the hospitalwide setting and large proportion of cases of communityacquired bacteremia (61%) in that study hampers comparison with the results we obtained.
Previous studies have identified important associations between antibiotic resistance and negative outcome for patients with gram-negative bacteremia [19] [20] [21] . However, causality remains unclear, and differences in study populations impede comparison with the present study.
It is a possible weakness in our study that the outcome comparison between the 2 groups of patients might be con-founded by differences in the clinical virulence of the types of gram-negative bacteria involved [16] . For example, 80% of Acinetobacter species, which are considered to be low-virulence pathogens, were AB-R, whereas 37% of Pseudomonas isolates, which are known to be extremely virulent, were AB-R. Regardless, in the multivariate survival analysis, no individual microorganism was recognized as being an independent predictor of mortality. Therefore, we assume that the confounding effect of differences in clinical virulence of the different types of bacteria seen in our study is of minor importance. However, outcome evaluation after stratification for different bacteria can be interesting.
In a prospective cohort study involving patients with bacteremia caused exclusively by Enterobacter species, Chow et al. [21] describe greater morbidity and mortality among patients with bacteremia caused by AB-R Enterobacter species. Our study included 68 ICU patients with bacteremia caused by Enterobacter, 37 of whom were infected with AB-R strains. Although these numbers are small and, therefore, are difficult to interpret, the mortality rates in these subgroups were nearly equal (35.5% and 35.1%, respectively), raising doubts about whether a worse prognosis was associated with bacteremia caused by AB-R Enterobacter species in our population. Also, when data were stratified by other frequently detected gram-negative microorganisms, no statistically significant differences in the mortality rates were found for the AB-S group and the AB-R group (table 3) . Nonetheless, the differences in the mortality rates for patients with bacteremia caused by AB-S or AB-R strains of Klebsiella species, E. coli, and, in particular, Acinetobacter species, which reached borderline significance ( ), are noteworthy. These P ! .1 results, however, must be interpreted cautiously because of the small numbers of patients included.
It can be presumed that bacteremia caused by AB-R bacteria may have a worse prognosis because of the delay in initiation of appropriate antibiotic therapy [22, 23] . Especially when highvirulence microorganisms such as P. aeruginosa are involved, early initiation of appropriate therapy is crucial to the survival of the patient [24, 25] . In our study, patients with AB-R bacteremia were treated appropriately at a rate similar to that for patients with AB-S bacteremia. The delay in the initiation of appropriate treatment was longer in the AB-R group, but the difference we found was of no significance, either statistically or clinically (table 2) .
The high rate of administration of appropriate therapy that was achieved in our ICU population can be explained by 3 factors: (1) consideration of previous colonization, as assessed by regular site-specific surveillance cultures (3 times weekly), (2) initial administration of broad-spectrum antibiotic therapy, and (3) close interaction between the physician, clinical microbiologists, and clinical infectious diseases consultants. This strategy appeared to contribute to a delay in administration of appropriate antibiotic treatment that was short (!1 day) overall in our study. Surveillance sampling was found to have a high specific and negative predictive value, because colonization preceded infection in almost all patients who had P. aeruginosa infection in the ICU [26, 27] . On the other hand, performing surveillance cultures routinely is expensive. Furthermore, whether this policy has greater clinical benefits than does initiation of blind therapy with broad-spectrum antibiotics is still controversial. It is well understood that blind therapy is restricted to a smaller spectrum, once microbiologic identification is completed, yet it might be assumed that this promotes the emergence of AB-R microorganisms, because there is more exposure to broad-spectrum antibiotics. Our strategy is to reserve these agents for patients with sepsis whose condition is deteriorating and for whom no isolate has been obtained from the presumed septic focus and for patients who have microbiologically proved superinfection.
Patients with AB-R bacteremia had a significantly longer stay in the ICU, as well as in the hospital. However, when length of ICU stay and length of hospitalization (from the day of the onset of bacteremia to discharge or death) were compared, no difference was found. We conclude from this that the excess length of stay, both in the ICU and the hospital, is a result of a longer ICU and hospital stay before the onset of the bacteremia. Consequently, it appears that cases of AB-R bacteremia are not responsible for the increased need for hospital resources among these patients but that risk factors for the acquisition of AB-R infections are the major triggers of this problem.
In conclusion, we found that AB-R gram-negative bacteremia is not associated with higher mortality than is AB-S gramnegative bacteremia in critically ill patients. AB-R bacteremia is associated with a longer stay in the ICU, as well as in the hospital. This, however, is the consequence of a longer stay before the onset of the bacteremia, whereas length of stay in the ICU and length of stay in the hospital after onset of the bacteremia in the 2 group of patients were not different.
